JINZHEN for Treatment of Mild to Moderate COVID-19

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
JINZHEN is a botanical drug that contains eight chemical constituents extracted from plant, mineral and animal origin raw materials. This study is to evaluate the safety and efficacy of JINZHEN Granules for Oral Solution compared to placebo for treatment of mild to moderate COVID-19 outpatients.
Epistemonikos ID: 72e6bc1f3fc081198fb15df622b94697ff568195
First added on: Oct 26, 2021